FDA Investigator Sharmista Chatterjee
Sharmista Chatterjee has conducted inspections on 3 sites in 3 countries as of 04 May 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
3
Last Inspection Date:
04 May 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United Kingdom of Great Britain and Northern Ireland,
Puerto Rico,
United States of America
FDA Investigators that have inspected at least one site in common with Sharmista Chatterjee:
Angelica M Hernandez,
Arie C Menachem,
Ariel Cruz Figueroa,
Arlene M Badillo,
Arwa S El Hagrasy,
Binh T Nguyen,
Bogdan Kurtyka,
Brenda P King,
Camerson E Moore,
CDR Ileana Barreto Pettit,
Celia N Cruz,
Charisse K Green,
Christina Capacci Daniel, PhD,
Colleen F Hoyt,
Craig T Rybus,
Darin S Wiegers,
Dennis Cantellops Paite,
Donna Christner,
Edmund F Mrak, Jr,
Erika V Butler,
Feiyan Jin,
Iraida Ortiz,
Ivis L Negron,
Jorge L Guadalupe,
Jose A Lopez,
Jose A Moreno,
José E Meléndez,
Jose Velez,
Kenneth H Williams,
Laurimer Kuilan Torres,
Libia M Lugo,
Linda Linh N Adams,
Lisa M Lopez,
Megan A Haggerty,
Michael E Maselli,
Michael R Goga,
Mra Davism,
Myriam M Sosa,
Noreen Muñiz,
Pamela L Ogonowski,
Paraluman S Leonin,
Patrice S Hall,
Patrick C Klotzbuecher,
Patrick L Wisor,
Ramon A Hernandez,
Raquel Gonzalez Rivera,
Rebeca M Melendez,
Rebecca Rodriguez,
Richard L Rutherford,
Robert J Martin,
Russell J Glapion,
Samina S Khan,
Sandra P White,
Sean R Marcsisin,
Shirley S Wen,
Steven D Kehoe,
Vilmary Negron Rodriguez,
Vioela J Caze,
Xiaohui Shen,
Yong Hu
Sharmista Chatterjee's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2016 | FDA 483 | Janssen Ortho LLC - Form 483, 2016-02-26 |
February, 2016 | EIR | Janssen Ortho LLC - EIR, 2016-02-26 |
September, 2017 | FDA 483 | Vertex Pharmaceuticals Incorporated - Form 483, 2017-09-07 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more